Aliqopa Side Effects

Generic name: copanlisib

Medically reviewed by Drugs.com. Last updated on Jun 9, 2024.

Note: This document provides detailed information about Aliqopa.

Applies to copanlisib: intravenous powder for solution Side Effects associated with copanlisib. Some dosage forms listed on this page may not apply specifically to the brand name Aliqopa.

Applies to copanlisib: intravenous powder for solution.

Precautions

It is very important that your doctor check your progress at regular visits to make sure this medicine is working properly. Blood tests may be needed to check for unwanted effects.

Using this medicine while you are pregnant can harm your unborn baby. If you are a woman who can get pregnant, your doctor may do tests to make sure you are not pregnant before starting treatment. This medicine may also cause birth defects if the father is using it when his sexual partner becomes pregnant. Female patients should use an effective form of birth control during treatment with this medicine and for 1 month after the last dose. Male patients who have female partners should use an effective birth control during treatment with this medicine and for 1 month after the last dose. If you think you have become pregnant or your partner has become pregnant while using this medicine, tell your doctor right away.

Call your doctor right away if you have fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination. These may be symptoms of an infection.

This medicine may increase your blood sugar levels. Check with your doctor right away if you have blurred vision, dry mouth, fatigue, flushed, dry skin, fruit-like breath odor, increased hunger, increased thirst, increased urination, nausea, stomach pain, sweating, trouble breathing, unexplained weight loss, or vomiting.

Your blood pressure might get too high while you are using this medicine. This may cause headaches, dizziness, or blurred vision. You might need to measure your blood pressure at home. If you think your blood pressure is too high, call your doctor right away.

This medicine may cause swelling of the lungs (pneumonitis). Check with your doctor right away if you have new or worsening cough, fever, or trouble breathing.

Copanlisib scan temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.

Serious skin reactions can occur with this medicine. Check with your doctor right away if you have blistering, peeling, or loosening of the skin, red skin lesions, severe acne or a skin rash, sores or ulcers on the skin, or fever or chills with this medicine.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Serious side effects of Aliqopa

Along with its needed effects, copanlisib (the active ingredient contained in Aliqopa) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking copanlisib:

Other side effects of Aliqopa

Some side effects of copanlisib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

For healthcare professionals

Applies to copanlisib: intravenous powder for injection.

General adverse events

The most common (20% or greater) adverse reactions were hyperglycemia, decreased hemoglobin, decreased lymphocyte count, decreased white blood cell count, decreased platelet count, decreased neutrophil count, hypertriglyceridemia, hypophosphatemia, diarrhea, decreased general strength and energy, hypertension, leukopenia, neutropenia, nausea, hyperuricemia, thrombocytopenia, lower respiratory tract infections, and increased serum lipase.^[Ref]

Endocrine

• Very common (10% or more): Hyperglycemia (95%)^[Ref]

Hematologic

• Very common (10% or more): Decreased hemoglobin (78%), decreased lymphocyte count (78%), decreased white blood cell count (71%), decreased platelet count (65%), decreased neutrophil count (63%), leukopenia (36%), neutropenia/febrile neutropenia (32%), thrombocytopenia (22%)^[Ref]

Metabolic

• Very common (10% or more): Hypertriglyceridemia (58%), hypophosphatemia (44%), increased serum lipase (21%)^[Ref]

Gastrointestinal

• Very common (10% or more): Diarrhea (36%), nausea (26%), stomatitis/oral pain/oropharyngeal erosion and ulcer (14%), vomiting (13%)^[Ref]

Other

• Very common (10% or more): Decreased general strength and energy/fatigue/asthenia (36%)
• Common (1% to 10%): Mucosal inflammation^[Ref]

Genitourinary

• Very common (10% or more): Hyperuricemia (25%)^[Ref]

Respiratory

• Very common (10% or more): Lower respiratory tract infections (21%)
• Common (1% to 10%): Pneumonitis^[Ref]

Nervous system

• Common (1% to 10%): Paresthesia, dysesthesia^[Ref]

Dermatologic

• Very common (10% or more): Rash/exfoliative skin reactions (15%)^[Ref]

Cardiovascular

• Very common (10% or more): Hypertension/secondary hypertension (13%)^[Ref]

See also:

Further information

Aliqopa side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer